Register

COURSE DESCRIPTION:
Over the past four decades, there has been a significant increase in obesity among adults. Additionally, a link has been determined between obesity and gastrointestinal disorders. This association offers gastroenterologists an excellent opportunity to manage obesity. Please join us for an engaging and informative discussion on Strategies for Weight Management for the Gastroenterologistwith Dr. Michelle Pearlman as she defines obesity and discusses its prevalence, trends and complications. Dr. Pearlman will also review and discuss common post-bariatric complications and nonsurgical management.

TARGET AUDIENCE:
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Define obesity and understand its prevalence, trends and complications.
• Explain noninvasive strategies for weight management (medical nutritional therapy, pharmacotherapy and endo-bariatrics).
• Review and discuss common post-bariatric complications and nonsurgical management.

​​​​​​​FACULTY AND DISCLOSURES:

Michelle Pearlman, M.D.
Bariatric Medicine, Gastroenterology
Division of Digestive and Liver Diseases
University of Miami Miller School of Medicine
Miami, Florida

Michelle Pearlman, M.D.​​​​​​​, faculty for this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.  

Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855841, by the Florida Boards of Medicine, Podiatry, Dentistry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.